Calhoun Center for Cardiology, University of Connecticut Health Center, Farmington, CT, USA.
Departments of Ophthalmology and Cardiovascular Medicine, Byers Eye Institute and Spencer Center for Vision Research, Stanford Cardiovascular Institute, Stanford University, Palo Alto, CA, USA.
J Physiol. 2020 Jul;598(14):3029-3042. doi: 10.1113/JP276756. Epub 2018 Dec 26.
The ubiquitous Ca /calmodulin-dependent phosphatase calcineurin is a key regulator of pathological cardiac hypertrophy whose therapeutic targeting in heart disease has been elusive due to its role in other essential biological processes. Calcineurin is targeted to diverse intracellular compartments by association with scaffold proteins, including by multivalent A-kinase anchoring proteins (AKAPs) that bind protein kinase A and other important signalling enzymes determining cardiac myocyte function and phenotype. Calcineurin anchoring by AKAPs confers specificity to calcineurin function in the cardiac myocyte. Targeting of calcineurin 'signalosomes' may provide a rationale for inhibiting the phosphatase in disease.
无处不在的 Ca/钙调蛋白依赖性磷酸酶钙调神经磷酸酶是病理性心肌肥厚的关键调节因子,但其在心脏病中的治疗靶点一直难以捉摸,因为它在其他重要的生物学过程中发挥作用。钙调神经磷酸酶通过与支架蛋白(包括多价 A 激酶锚定蛋白(AKAPs))结合而被靶向到各种细胞内隔室,AKAPs 结合蛋白激酶 A 和其他决定心肌细胞功能和表型的重要信号酶。AKAP 对钙调神经磷酸酶的锚定赋予了钙调神经磷酸酶在心肌细胞中功能的特异性。钙调神经磷酸酶“信号体”的靶向可能为抑制磷酸酶在疾病中的作用提供了一种合理的依据。